CD44 and cancer: For furthermore analysis, we utilized The Cancer Genome Atlas (TCGA) public database and identified GSK3β, β-Catenin, STAT3, and CD44 oncogenes to be overexpressed in GBM tumor samples compared to adjacent normal tissue groups, and this was associated with poor cancer prognoses (Figure 2).